Senior Scientist
Merck & Co., Inc.
Rahway, New Jersey
Dr. Jiaying Liu is currently a senior scientist and an experienced formulator in Merck & Co. Inc. Prior to joining Merck, she got her PhD degree in biomedical engineering from Georgia Institute of Technology and Emory University, where she studied drug delivery approaches for nucleic acids, protein and adjuvants using novel nano/microparticulate systems, invented a new type of multivalent artificial antibody, and worked on multiple gene therapy products and cancer vaccines, which resulted in many publications in peer-reviewed journals and patents.She joined Merck Oral Formulation Sciences Department in 2019 and has since led and contributed to the development of many oral drug products, including two that are already FDA approved, Welireg for VHL disease and kidney cancer, and Lagevrio, the oral anti-COVID-19 capsules. She has experience in various therapeutic areas, such as oncology, infectious diseases, HIV/AIDS, neurosciences and all phases, from pre-IND to commercialization. She also has strong expertise in crystalline formulations, amorphous solid dispersions, oral suspensions and pediatric formulation. She is especially passionate to develop innovative drug delivery approaches to enhance oral bioavailability of small molecules and peptides and has established herself as one of the experts of this field in Merck.
Disclosure information not submitted.
Wednesday, October 19, 2022
3:00 PM – 3:15 PM ET